FDA inspection
Recipharm Strangnas AB: FDA inspection ending Sep 6, 2019
FDA inspection 1101934 · Voluntary Action Indicated (VAI) · Strangnas
Key facts
| Inspection ID | 1101934 |
|---|---|
| Firm | Recipharm Strangnas AB |
| FEI number | 3006524831 |
| Address | Mariefredsvagen 35 |
| City | Strangnas |
| Fiscal year | 2019 |
| Inspection end date | Sep 6, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data